Loading
Latest filing published 18 Oct 2019 for Medicenna Therapeutics Corp..
No signal scores available.
This profile gathers the share dealings of Andrew Strong in Medicenna Therapeutics Corp. We count 4 filings; the first trade dates from 1 March 2017 and the latest from 17 October 2019.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
On 18 October 2019 came the latest disclosure, a transaction in Medicenna Therapeutics Corp. These figures are compiled from regulatory filings published by SEDI. They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 of 4 declarations